Multicenter Single-arm Pilot Study Evaluating Efficacy of Nilotinib in CML Patients With Molecular Relapse After Glivec Discontinuation Within the Context of the STIM Trials (STIM and STIM2)
Clinical trial NCT01774630 · COMPLETED
Trial details
- NCT number
- NCT01774630
- Sponsor
- University Hospital, Bordeaux
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-10
- Primary completion
- 2020-12-21
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.